Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.
about
Key role of tissue plasminogen activator in neurovascular couplingEffects of Two Different Dietary Patterns on Inflammatory Markers, Advanced Glycation End Products and Lipids in Subjects without Type 2 Diabetes: A Randomised Crossover Study.Plasma fibrinolysis inhibitor levels in acute stroke patients with thrombolysis failure.Impaired fibrinolysis in the antiphospholipid syndrome.The effect of secretory factors of adipose-derived stem cells on human keratinocytes.Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice.PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stentingHIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.Plasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population.Pathophysiology of peripheral arterial disease in diabetes mellitus.Non-conventional markers of atherosclerosis before and after gastric banding surgery.Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.Remarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex.Effects of Weight Loss on Advanced Glycation End Products in Subjects with and without Diabetes: A Preliminary Report.The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1.Idiopathic intracranial hypertension: associations with thrombophilia and hypofibrinolysis in men.The role of fibrinolytic and antifibrinolytic activities in the pathophysiology of HELLP syndrome.Plasminogen activator inhibitor-1 polymorphisms (−844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables
P2860
Q28512912-189ADEAB-03C1-4602-90A7-90B0B05AEF43Q33616622-B40F92C0-FA76-4CC3-8EA9-B9455BB5754BQ33790622-18E2CDAA-92EE-4844-97BF-90EE072A2CE7Q33822542-735B687B-4040-4CC1-8A6A-E48DEE631616Q34152565-820CECA2-FDD1-4C65-B131-E6D5ABDC9BC9Q34630452-B58A463B-E42F-49E8-97E6-92B40342B5DAQ34978504-38AD7250-8344-4F6D-BB5B-B1ACB1E520A8Q35771481-5485F90A-30ED-4CCE-A3D8-C5B550C37C2AQ37195539-14E5286B-4B8E-4FBA-869C-067546B01241Q37434624-CFD65A98-AB34-47E2-9266-0F675D95090BQ38936026-2B739526-0D4D-42DB-B817-476FF7F36A73Q39986083-2ACE2084-65F7-4A86-8138-64B4C00ADF64Q40839885-79539DDB-8B4B-492D-9386-43AD7AD87577Q42836856-3D7AA534-BD73-4A41-BB94-046DEEA5BCC2Q46242862-954FA61F-4884-4422-B35E-F9CA35E7D26EQ46707376-7797C6F8-8C03-40F6-9519-679813AE3A5AQ46770296-A815E9CC-F12A-4D25-B735-6EDB1047C536Q53947453-95F37F6B-AB72-4BBB-93D1-8685812F42F2Q58052078-71DA4861-BE40-4B05-9E00-E1D23E536EB5
P2860
Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Plasminogen activator inhibito ...... le for thromboembolic disease.
@ast
Plasminogen activator inhibito ...... le for thromboembolic disease.
@en
Plasminogen activator inhibito ...... le for thromboembolic disease.
@nl
type
label
Plasminogen activator inhibito ...... le for thromboembolic disease.
@ast
Plasminogen activator inhibito ...... le for thromboembolic disease.
@en
Plasminogen activator inhibito ...... le for thromboembolic disease.
@nl
prefLabel
Plasminogen activator inhibito ...... le for thromboembolic disease.
@ast
Plasminogen activator inhibito ...... le for thromboembolic disease.
@en
Plasminogen activator inhibito ...... le for thromboembolic disease.
@nl
P356
P1476
Plasminogen activator inhibito ...... le for thromboembolic disease.
@en
P2093
P2888
P304
P356
10.1023/A:1011955018052
P577
2001-05-01T00:00:00Z
P6179
1015297290